Collectively, these data demonstrated that the ITGA family of ITGA2 and ITGA3 are novel oncogenes in CSCC and may be new therapeutic targets for cervical squamous cell carcinoma. This evidence concerns the gene ITGA2 and cervical squamous cell carcinoma.